FOXP3 and neoplasm: Immunohistochemical analysis showed that lacidipine (0.5, 1, and 20 mg kg−1) in combination with DOX/cisplatin increased CD8 expression and decreased Foxp3 expression in tumor tissues (Figure 3B,C and Figure S3C, Supporting Information).